First time in history! Experimental drug trial removes cancer entirely in a group of 18 people; know about this miraculous study | The Times of India

“It’s what cancer doctors’ dreams are made of,” Dr. Andrea Cercek, the researchers and a co-author of the paper said on the massive breakthrough research.

The research study, which has been published in the New England Journal of Medicine, was based on finding out if dostarlimab coupled with chemoradiotherapy and standard surgery is an effective treatment against tumors.

A total of 32 authors have been listed in the research paper which was supported by the Simon and Eve Colin Foundation, GlaxoSmithKline, Stand Up to Cancer, Swim Across America, and the National Cancer Institute of the National Institutes of Health.

The patients who have participated in the study did not have any chemoradiotherapy or surgery and as per the research study no case of progression or recurrence of the disease was reported during the follow up between 6 to 25 months.

“A total of 12 patients have completed treatment with dostarlimab and have undergone at least 6 months of follow-up. All 12 patients (100%; 95% confidence interval, 74 to 100) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging, F-fluorodeoxyglucose–positron-emission tomography, endoscopic evaluation, digital rectal examination, or biopsy,” the research paper reads.

Source link

Leave a Reply

Your email address will not be published.